XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation and Shareholders' Equity
9 Months Ended
Aug. 03, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation and Shareholders' Equity Stock-Based Compensation and Shareholders' Equity
A summary of the Company’s stock option activity as of August 3, 2019 and changes during the three- and nine-month periods then ended is presented below:
Activity During The Three Months Ended August 3, 2019
Options
Outstanding
(in thousands)
 
Weighted-
Average Exercise
Price Per Share
 
Weighted-
Average
Remaining
Contractual
Term in Years
 
Aggregate
Intrinsic
Value
Options outstanding at May 4, 2019
5,822

 

$64.99

 
 
 
 
Options granted
14

 

$108.06

 
 
 
 
Options exercised
(360
)
 

$54.07

 
 
 
 
Options forfeited
(85
)
 

$85.29

 
 
 
 
Options outstanding at August 3, 2019
5,391

 

$65.51

 
6.1
 

$254,294

Options exercisable at August 3, 2019
3,117

 

$55.04

 
5.0
 

$179,685

Options vested or expected to vest at August 3, 2019 (1)
5,227

 

$64.90

 
6.1
 

$249,744


 
(1)
In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options.
Activity During The Nine Months Ended August 3, 2019
Options
Outstanding
(in thousands)
 
Weighted-
Average Exercise
Price Per Share
Options outstanding at November 3, 2018
7,297

 

$58.42

Options granted
454

 

$107.11

Options exercised
(2,168
)
 

$49.38

Options forfeited
(187
)
 

$78.03

Options expired
(5
)
 

$21.97

Options outstanding at August 3, 2019
5,391

 

$65.51


During the three- and nine-month periods ended August 3, 2019, the total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) was $21.0 million and $120.7 million, respectively, and the total amount of proceeds received by the Company from the exercise of these options was $19.2 million and $106.1 million, respectively.
During the three- and nine-month periods ended August 4, 2018, the total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) was $29.3 million and $111.9 million, respectively, and the total amount of proceeds received by the Company from the exercise of these options was $22.8 million and $88.4 million, respectively.
A summary of the Company’s restricted stock unit/award activity as of August 3, 2019 and changes during the three- and nine-month periods then ended is presented below: 
Activity During The Three Months Ended August 3, 2019
Restricted
Stock Units/Awards
Outstanding
(in thousands)
 
Weighted-
Average Grant-
Date Fair Value
Per Share
Restricted stock units/awards outstanding at May 4, 2019
4,978

 

$85.49

Units/Awards granted
96

 

$95.68

Restrictions lapsed
(304
)
 

$79.38

Forfeited
(90
)
 

$81.62

Restricted stock units/awards outstanding at August 3, 2019
4,680

 

$86.17

 
 
 
 
Activity During The Nine Months Ended August 3, 2019
Restricted
Stock Units/Awards
Outstanding
(in thousands)
 
Weighted-
Average Grant-
Date Fair Value
Per Share
Restricted stock units/awards outstanding at November 3, 2018
5,289

 

$77.54

Units/Awards granted
1,296

 

$97.88

Restrictions lapsed
(1,635
)
 

$68.49

Forfeited
(270
)
 

$79.55

Restricted stock units/awards outstanding at August 3, 2019
4,680

 

$86.17

As of August 3, 2019, there was $358.4 million of total unrecognized compensation cost related to unvested stock-based awards comprised of stock options and restricted stock units/awards. That cost is expected to be recognized over a weighted-average period of 1.54 years. The total grant-date fair value of shares that vested during the three- and nine-month periods ended August 3, 2019 was approximately $24.6 million and $131.0 million, respectively. The total grant-date fair value of shares that vested during the three- and nine-month periods ended August 4, 2018 was approximately $28.2 million and $112.7 million, respectively.
Common Stock Repurchases
As of August 3, 2019, the Company had repurchased a total of approximately 152.9 million shares of its common stock for approximately $5.9 billion under the Company's share repurchase program. As of August 3, 2019, an additional $2.2 billion remains available for repurchase of shares under the current authorized program.